Package 43598-863-60

{"route": ["ORAL"], "spl_id": "4486fd29-bab2-59ee-e063-6294a90a4fd2", "openfda": {"upc": ["0343598863603"], "unii": ["ZG7E5POY8O"], "rxcui": ["1801289"], "spl_set_id": ["8069c521-c49a-4b6d-baa8-4b0be897d585"], "manufacturer_name": ["Dr. Reddy's Laboratories Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (43598-863-10)", "package_ndc": "43598-863-10", "marketing_start_date": "20160817"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43598-863-30)", "package_ndc": "43598-863-30", "marketing_start_date": "20160817"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (43598-863-60)", "package_ndc": "43598-863-60", "marketing_start_date": "20160817"}], "brand_name": "BUPROPION HYDROCHLORIDE (SR)", "product_id": "43598-863_4486fd29-bab2-59ee-e063-6294a90a4fd2", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "43598-863", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Dr. Reddy's Laboratories Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE (SR)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA206122", "marketing_category": "ANDA", "marketing_start_date": "20160817", "listing_expiration_date": "20261231"}